PL3431609T3 - Sposób diagnozowania raka jelita grubego - Google Patents

Sposób diagnozowania raka jelita grubego

Info

Publication number
PL3431609T3
PL3431609T3 PL17181646T PL17181646T PL3431609T3 PL 3431609 T3 PL3431609 T3 PL 3431609T3 PL 17181646 T PL17181646 T PL 17181646T PL 17181646 T PL17181646 T PL 17181646T PL 3431609 T3 PL3431609 T3 PL 3431609T3
Authority
PL
Poland
Prior art keywords
diagnosis
colorectal cancer
colorectal
cancer
Prior art date
Application number
PL17181646T
Other languages
English (en)
Polish (pl)
Inventor
Ondrej SLABY
Petra Vychytilova
Marek Svoboda
Milana Sachlova
Original Assignee
Masarykova Univerzita
Masarykuv Onkologicky Ustav
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Masarykova Univerzita, Masarykuv Onkologicky Ustav filed Critical Masarykova Univerzita
Publication of PL3431609T3 publication Critical patent/PL3431609T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL17181646T 2017-07-17 2017-07-17 Sposób diagnozowania raka jelita grubego PL3431609T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17181646.5A EP3431609B1 (fr) 2017-07-17 2017-07-17 Procédé de diagnostic du cancer colorectal

Publications (1)

Publication Number Publication Date
PL3431609T3 true PL3431609T3 (pl) 2020-11-02

Family

ID=59363020

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17181646T PL3431609T3 (pl) 2017-07-17 2017-07-17 Sposób diagnozowania raka jelita grubego

Country Status (7)

Country Link
US (1) US20210130904A1 (fr)
EP (1) EP3431609B1 (fr)
JP (2) JP6989863B2 (fr)
ES (1) ES2785682T3 (fr)
HU (1) HUE048369T2 (fr)
PL (1) PL3431609T3 (fr)
WO (1) WO2019015702A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
EP3563859B1 (fr) 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Exosomes dérivés de cardiosphères pour la régénération de tissus
JP6878274B2 (ja) 2014-10-03 2021-05-26 シーダーズ−サイナイ・メディカル・センターCedars−Sinai Medical Center 筋ジストロフィーの処置における心筋球由来細胞およびこのような細胞によって分泌されたエキソソーム
WO2017123662A1 (fr) 2016-01-11 2017-07-20 Cedars-Sinai Medical Center Cellules dérivées de cardiosphères et exosomes sécrétés par ces cellules dans le traitement d'une insuffisance cardiaque à fraction d'éjection préservée
WO2017210652A1 (fr) 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Exosomes dérivés de cdc pour le traitement des tachyarythmies ventriculaires
US11541078B2 (en) 2016-09-20 2023-01-03 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
US11759482B2 (en) 2017-04-19 2023-09-19 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
HUE048369T2 (hu) * 2017-07-17 2020-07-28 Univ Masarykova Diagnosztikai eljárás végbélrák kimutatására
US11660355B2 (en) 2017-12-20 2023-05-30 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
CN111321222B (zh) * 2018-12-17 2024-01-19 北京大学肿瘤医院内蒙古医院(内蒙古医科大学附属肿瘤医院、内蒙古自治区肿瘤医院、内蒙古自治区癌症中心) 用于结直肠癌无创诊断的血清piRNA标志物及检测试剂盒
CN109913461B (zh) * 2019-04-01 2023-05-02 中国医科大学附属口腔医院 根尖牙乳头干细胞外泌体piRNA生物标志物及其筛选应用
AU2021275327A1 (en) * 2020-05-19 2022-12-08 Cedars-Sinai Medical Center Exosome-derived PIWI-interacting RNA and methods of use thereof
EP4130296A1 (fr) * 2021-08-03 2023-02-08 Deutsches Krebsforschungszentrum - Stiftung des öffentlichen Rechts / Universität Heidelberg Prédiction du cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501243B2 (en) 2001-02-21 2009-03-10 Novartis Vaccines And Diagnostics, Inc. Detection of colon or breast cancer by measuring TTK polypeptide expression
WO2004071267A2 (fr) 2003-02-11 2004-08-26 Roche Diagnostics Gmbh Diagnostic du cancer colono-rectal par detection de nicotinamide n-methyltransferase dans un echantillon de selles
WO2004079368A2 (fr) 2003-03-08 2004-09-16 Auvation Ltd Marqueurs cancereux
JP2006528340A (ja) 2003-08-07 2006-12-14 エフ.ホフマン−ラ ロシュ アーゲー 結腸直腸癌に対するマーカーとしてのタンパク質酸性リボソームタンパク質po(rla−0)の使用
WO2005015234A1 (fr) 2003-08-11 2005-02-17 Roche Diagnostics Gmbh Utilisation de la proteine sahh comme marqueur du cancer colorectal
KR101073875B1 (ko) 2008-11-28 2011-10-14 한국생명공학연구원 대장암 진단 마커 및 이를 이용한 대장암 진단방법
WO2011161960A1 (fr) 2010-06-23 2011-12-29 Oncotherapy Science, Inc. C1orf59 pour gènes cibles de thérapie et diagnostic du cancer
CN103627705B (zh) 2013-10-28 2016-02-24 南京医科大学 与膀胱癌相关的piRNA生物标志物及其应用
CN105483218B (zh) 2015-12-11 2018-08-07 南京大学 检测和/或预测男性生殖功能障碍的精浆piRNA标志物或其组合及其应用
HUE048369T2 (hu) * 2017-07-17 2020-07-28 Univ Masarykova Diagnosztikai eljárás végbélrák kimutatására

Also Published As

Publication number Publication date
JP2021090451A (ja) 2021-06-17
WO2019015702A1 (fr) 2019-01-24
US20210130904A1 (en) 2021-05-06
HUE048369T2 (hu) 2020-07-28
EP3431609A1 (fr) 2019-01-23
EP3431609B1 (fr) 2020-02-12
JP2020527047A (ja) 2020-09-03
JP6989863B2 (ja) 2022-01-12
ES2785682T3 (es) 2020-10-07

Similar Documents

Publication Publication Date Title
HUE048369T2 (hu) Diagnosztikai eljárás végbélrák kimutatására
HK1251409A1 (zh) 治療癌症的方法
IL275663A (en) Cancer treatment methods
ZA201804227B (en) Methods of treating cancer
IL256025A (en) Methods of diagnosing and treating cancer
GB201511152D0 (en) Method of diagnosing bladder cancer
GB2545361B (en) Methods of assessing colorectal cancer status
IL262005A (en) Methods of treating cancer in children
HK1247931A1 (zh) 用於診斷和治療癌症的組合物和方法
SG11201607130RA (en) Combination method for treatment of cancer
HK1253082A1 (zh) 診斷乳腺癌的方法
IL267675A (en) A method for treating advanced cancer expressing her2
SG10201913528PA (en) Methods of diagnosing cancer
ZA201908539B (en) Method of treatment of cancer
EP3183578B8 (fr) Méthodes de détection précoce du cancer colorectal
SG11201701076TA (en) Diagnosis of cancer
GB201513989D0 (en) Method of diagnosis of dysphagia
SG11202005163PA (en) Methods of treating cancer
GB201814350D0 (en) Diagnosis of cancer
GB201717945D0 (en) Method for treatment of cancer
HK1249134A1 (zh) 結直腸癌相關疾病的生物標誌物
PT3298165T (pt) Método e kit para diagnóstico de cancro colorretal
GB201513188D0 (en) Method of tomography
IL269123A (en) Methods of treating cancer
EP3389670A4 (fr) Méthodes de traitement du cancer du sein